PR Newswire Clinical TrialsOriginal article
WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
RegulatoryapprovedXpert® Hemorrhagic Fever Panel TestPositive
AI Analysis
Summary
Cepheid announced WHO Emergency Use Listing approval for its Xpert Hemorrhagic Fever Panel Test to support Ebola outbreak response in the Democratic Republic of Congo, leveraging its existing GeneXpert Dx system infrastructure across Africa.
Outcome Details
WHO Emergency Use Listing granted for Xpert Hemorrhagic Fever Panel Test
Importance:7/10
Sentiment:
0.80
WHO approvalemergency use listingmolecular diagnosticsEbolaAfricainfectious disease
Read the original article
Published by PR Newswire Clinical Trials on September 3, 2026 4:00 PM